We suggest to use Appili Therapeutics fundamental analysis to find out if markets are presently mispricing the company. Put another way you can use it to find out if Appili Therapeutics is indeed mispriced or if you can make any profits on it by purchasing it and then waiting for the market to recognize its mistake and reprise the security. We were able to break down and interpolate data for thirty-one available fundamental indicators for Appili Therapeutics, which can be compared to its peers. The stock experiences a very speculative upward sentiment. Check odds of Appili Therapeutics to be traded at C$0.019 in 90 days.
Cash Flow Balance Sheet Income Statement
Covid
Interest Hikes
Appili Therapeutics Balance Sheet Chart
At this time, Appili Therapeutics' Other Stockholder Equity is very stable compared to the past year. As of the 19th of February 2026, Total Liabilities is likely to grow to about 19.8 M, while Total Assets are likely to drop about 2.6 M.
Understanding current and past Appili Therapeutics Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Appili Therapeutics' financial statements are interrelated, with each one affecting the others. For example, an increase in Appili Therapeutics' assets may result in an increase in income on the income statement.
Appili Therapeutics competes with XORTX Therapeutics, and Aptose Biosciences. Appili Therapeutics Inc., a biopharmaceutical company, focuses on the acquisition and development of novel medicines for unmet needs in the infectious disease in Canada. Appili Therapeutics Inc. was incorporated in 2015 and is headquartered in Halifax, Canada. APPILI THERAPEUTICS is traded on Toronto Stock Exchange in Canada.
Foreign Associate
Canada
Specialization
Health Care, Pharmaceuticals, Biotechnology & Life Sciences
You should never invest in Appili Therapeutics without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Appili Stock, because this is throwing your money away. Analyzing the key information contained in Appili Therapeutics' financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Appili Therapeutics Key Financial Ratios
Appili Therapeutics' financial ratios allow both analysts and investors to convert raw data from Appili Therapeutics' financial statements into concise, actionable information that can be used to evaluate the performance of Appili Therapeutics over time and compare it to other companies across industries.
Comparative valuation techniques use various fundamental indicators to help in determining Appili Therapeutics's current stock value. Our valuation model uses many indicators to compare Appili Therapeutics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Appili Therapeutics competition to find correlations between indicators driving Appili Therapeutics's intrinsic value. More Info.
Appili Therapeutics is rated fifth in return on equity category among its peers. It is rated below average in return on asset category among its peers . At this time, Appili Therapeutics' Return On Equity is very stable compared to the past year. Comparative valuation analysis is a catch-all model that can be used if you cannot value Appili Therapeutics by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Appili Therapeutics' Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.
Appili Therapeutics Total Assets Over Time
Most indicators from Appili Therapeutics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Appili Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Appili Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in inflation.
Today, most investors in Appili Therapeutics Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Appili Therapeutics' growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Appili Therapeutics growth as a starting point in their analysis.
Appili Therapeutics February 19, 2026 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Appili Therapeutics help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Appili Therapeutics. We use our internally-developed statistical techniques to arrive at the intrinsic value of Appili Therapeutics based on widely used predictive technical indicators. In general, we focus on analyzing Appili Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Appili Therapeutics's daily price indicators and compare them against related drivers.
Appili Therapeutics financial ratios help investors to determine whether Appili Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Appili with respect to the benefits of owning Appili Therapeutics security.